Clinical Trial Update: A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients [Phase 3]

View source ↗

Summary

Phase III trial evaluating the efficacy and safety of SYH9056 (valsartan/levamlodipine) tablets in patients with mild-to-moderate essential hypertension. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Valsartan/Levamlodipine (SYH9056) Tablets (Valsartan/Levamlodipine)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Mild-to-moderate Essential Hypertension | Phase 3 | Status: NOT_YET_RECRUITING